top of page


Understanding the SANGUINE Project: A Biomarker Project Overview
The SANGUINE Project represents a significant advancement in the early detection of hematological malignancies. This initiative aims to transform cancer care across Europe by introducing a cutting-edge blood test designed to identify blood cancers at their earliest stages. Early detection is crucial for improving patient outcomes and quality of life, and the SANGUINE Project is poised to become a standard tool in clinical practice. Biomarker Project Overview: The Foundation o
webmaster0593
Mar 94 min read
Â
Â
Â


FZMB SANGUINE Project Role: Advancing Early Detection of Hematological Malignancies
The fight against hematological malignancies demands innovative approaches and collaborative efforts. The SANGUINE project represents a significant leap forward in this battle by developing a cutting-edge blood test designed for early detection of blood cancers. My focus here is to explore FZMB's contribution to the SANGUINE project and how it supports the goal of transforming cancer care across Europe. Understanding FZMB's SANGUINE Project Role FZMB plays a pivotal role in
webmaster0593
Sep 27, 20253 min read
Â
Â
Â


The SANGUINE Project: Transforming Early Detection of Blood Cancers
The SANGUINE project continues to make significant strides in the early detection of hematological malignancies through its innovative blood test technology. This initiative aims to transform cancer care across Europe by establishing a reliable, non-invasive diagnostic tool that can identify blood cancers at their earliest stages. In this post, I will share the latest updates on the project’s progress, technological advancements, and upcoming milestones. These developments ar
webmaster0593
Jul 11, 20244 min read
Â
Â
Â


Israel Channel 13 News (French)
On May 2023, the Ebenstein lab and the SANGUINE project, in particular, were featured in one of the main news channels in Israel. The...
webmaster0593
Oct 6, 20231 min read
Â
Â
Â


PR of FZMB (German)
FZMB released PR in several local channels, presenting the SANGUINE project. Also here, here, and here.
webmaster0593
Oct 6, 20231 min read
Â
Â
Â


SANGUINE clinical trial is listed on NIH
The SANGUINE clinical trial is listed in NIH, at ClinicalTrials.gov, with identifier: NCT05735704.
webmaster0593
Oct 6, 20231 min read
Â
Â
Â
Go to the Events page
bottom of page